This is the authors' abstract. We don't add key points for this paper.
Using an algorithm including both enzyme immunoassay (EIA) and nucleic acid amplification (NAAT) for Clostridium difficile infection (CDI) diagnosis, we found that the use of NAAT versus EIA almost doubled our hospital-onset CDI laboratory-identified (LabID) event standardized infection ratio (SIR). We recommend that the current risk adjustment approach be modified. Infect Control Hosp Epidemiol 2016:1-3.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Marra et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: